GEHC logo

GE HealthCare Technologies Inc. (GEHC)

$80.64

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on GEHC

Market cap

$36.46B

EPS

4.73

P/E ratio

15.1

Price to sales

1.4

Dividend yield

0.198%

Beta

0.76761

Price on GEHC

Previous close

$81.89

Today's open

$82.50

Day's range

$80.29 - $83.07

52 week range

$58.75 - $89.77

Profile about GEHC

CEO

Peter J. Arduini

Employees

54000

Headquarters

Chicago, IL

Exchange

Nasdaq Global Select

Shares outstanding

452137831

Issue type

Common Stock

GEHC industries and sectors

Healthcare

Medical Diagnostics & Screening

News on GEHC

GEHC Advances Manganese-Based MRI Agent to Phase 3 After Positive Data

GE HealthCare advances manganese-based MRI agent to Phase 3 after positive trial data, potentially expanding its imaging portfolio and addressing gadolinium-related concerns.

news source

Zacks Investment Research • 19 hours ago

news preview

GE HealthCare introduces new Imaging 360 features to simplify protocol management and support radiology workflows

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced two new capabilities for Imaging 360, AI assistant and AI-assisted protocoling. The Imaging 360 AI assistant and AI-assist protocoling are designed to help imaging teams quickly find answers to protocol-related questions and support protocoling for CT and MR exams. Radiology departments manage complex workflows across sites, systems and care teams. Finding protocol information and analyzing the data can be time consuming. Se.

news source

Business Wire • a day ago

news preview

GE HealthCare Foundation announces 2026 grants to expand maternal and pediatric care in underserved communities

CHICAGO--(BUSINESS WIRE)--The GE HealthCare Foundation today announced its 2026 cohort of grant recipients, supporting organizations whose work will help expand access to lifesaving care for mothers and children around the world. This year's grantees are focused on building sustainable, technology-enabled healthcare infrastructure, equipping frontline healthcare workers with point-of-care diagnostics and advanced surgical training. Spanning three continents, these investments reflect the Founda.

news source

Business Wire • 17 hours ago

news preview

Why GE HealthCare Technologies (GEHC) is a Top Stock for the Long-Term

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

news source

Zacks Investment Research • Nov 19, 2026

news preview

GE HealthCare Wins FDA Nod for AI Feeding Tube Detection Software

GEHC secures FDA clearance for AI-powered feeding tube detection software, expanding bedside X-ray capabilities for adult and pediatric patients.

news source

Zacks Investment Research • Nov 19, 2026

news preview

GE HealthCare's Phase 2 Results Support Advancement of Investigational Manganese-Based MRI Contrast Agent Mangaciclanol Into Phase 3 of LUMINA Clinical Trial

CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced Phase 2 results support advancement into Phase 3 for its international, multicenter LUMINA trial of mangaciclanol, with a dose selection of 0.1mmol/kg. Mangaciclanol is an investigational manganese-based magnetic resonance imaging (MRI) contrast agent (MBCA). If approved, MBCAs could offer an alternative to – or even replace – gadolinium-based contrast agents (GBCAs), the current standard of care. This is.

news source

Business Wire • Nov 19, 2026

news preview

GE HealthCare Expands Global Research Network for Photon-Counting CT

GEHC expands its global research network for Photonova Spectra to advance photon-counting CT applications, clinical adoption and diagnostic capabilities.

news source

Zacks Investment Research • Nov 18, 2026

news preview

GE HealthCare brings advanced visualization into InteleViewer to support radiology workflows

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced the integration of the AW ONE ecosystem, a unified ecosystem for post processing and advanced visualization, with InteleViewer, IntelePACS' diagnostic viewer designed to support seamless radiology workflows.1 Clinicians can now launch advanced visualization and workflow automation applications in the AW ONE ecosystem directly within InteleViewer as they review and interpret images, without having to switch to a separate environmen.

news source

Business Wire • Nov 18, 2026

news preview

Here's Why You Should Add GEHC Stock to Your Portfolio Right Now

GE HealthCare's record backlog, strong Pharmaceutical Diagnostics growth and AI-powered innovations position it for long-term growth despite inflation and tariff risks.

news source

Zacks Investment Research • Nov 17, 2026

news preview

GE HealthCare expands global collaborations to help define the future of photon-counting CT with Photonova™ Spectra

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an expansion of its global clinical and research collaborations to advance Photonova Spectra,i the company's next-generation photon-counting CT system. Following recent global regulatory clearances, leading academic hospitals and research institutions across North America, Europe and Asia are beginning structured evaluations of Photonova Spectra to further define its clinical utility, optimize imaging protocols and explore n.

news source

Business Wire • Nov 16, 2026

news preview

¹ Disclosures

Get started with M1

Invest in GE HealthCare Technologies Inc.

Open an M1 investment account to buy and sell GE HealthCare Technologies Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in GEHC on M1